ArticleAnnals of medicine and surgery (2012)2026
The evolving role of interventional radiology in ophthalmology: advancements in imaging, therapeutic applications, and future prospects, a narrative review.
Article in Annals of medicine and surgery (2012), 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
0 citing papers in PubMed.
No citing paper in PubMed yet.
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
9 authors.
Funding
No grant is acknowledged in the PubMed record.
Abstract
Since its establishment, interventional radiology (IR) has played a crucial role in various medical fields, including ophthalmology, in treating various ocular conditions and improving patient outcomes. This review discusses the recent innovations, therapeutic applications, and existing challenges of IR in the ophthalmology field. Multiple modalities of IR, including magnetic resonance imaging, computed tomography (CT), ultrasound, fluorescein angiography, indocyanine green angiography, and optical coherence tomography angiography (OCTA), play a crucial role in diagnosing ocular diseases and tumors. Among them, OCTA, being non-invasive, is preferred over traditional methods for better visualization of ocular microvasculature. IR in eye care offers a less invasive treatment approach and high precision with procedures like targeted chemotherapy, embolization, and CT-guided biopsies. Application of IR in the eye demands high precision, but limitations include limited access to equipment, trained specialists, and high costs. By fusing advanced imaging, artificial intelligence, and nanotechnology for effective treatments, IR has proved revolutionary for eye care. As collaboration between specialists grows and new tools like simulation training and augmented reality/virtual reality improve precision and safety, challenges such as high costs and limited access to technology still need to be addressed. This review will highlight the role of IR in ophthalmology, including minimally invasive procedures and therapeutic approaches. The integration of IR has led to improvements in the management of ocular conditions, with better outcomes and minimal side effects, by enhancing precision and improving recovery time.
Indexed as
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.